Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

AUTOR(ES)

Locke, Cody

FONTE

MyJove Corporation

RESUMO

The nematode, Caenorhabditis elegans, has become an expedient model for studying neurotransmission. C. elegans is unique among animal models, as the anatomy and connectivity of its nervous system has been determined from electron micrographs and refined by pharmacological assays. In this video, we describe how two complementary neural stimulants, an acetylcholinesterase inhibitor, called aldicarb, and a gamma-aminobutyric acid (GABA) receptor antagonist, called pentylenetetrazole (PTZ), may be employed to specifically characterize signaling at C. elegans neuromuscular junctions (NMJs) and facilitate our understanding of antagonistic neural circuits.

Documentos Relacionados

• A genetic selection for Caenorhabditis elegans synaptic transmission mutants.
• Vectors for low copy transformation of C. elegans.
• Synaptic scaffolding protein SYD-2 clusters and activates kinesin-3 UNC-104 in C. elegans
• Cloning and characterization of the C. elegans histidyl-tRNA synthetase gene.
• Cloning by synteny: identifying C. briggsae homologues of C. elegans genes.